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33 Early pregnancy is characterised by elevated circulating levels of vitamin D binding protein (DBP). 
 
34 The impact of this on maternal and fetal health is unclear but DBP is present in the placenta, and 
 
35 DBP gene variants have been linked to malplacentation disorders such as preeclampsia. A 
 
36 functional role for DBP in the placenta was investigated using trophoblastic JEG3, BeWo and 
 
37 HTR8 cells. All three cells lines showed intracellular DBP, with increased expression and nuclear 
 
38 localisation of DBP in cells treated with the active form of vitamin D, 1,25-dihydroxyvitamin D 
 
39 (1,25D). When cultured in serum from mice lacking DBP (DBP-/-), JEG3 cells showed no 
 
40 intracellular DBP indicating uptake of exogenous DBP. Inhibition of the membrane receptor for 
 
41 DBP, megalin, also suppressed intracellular DBP. Elimination of intracellular DBP with DBP-/- 
 
42 serum or megalin inhibitor suppressed matrix invasion by trophoblast cells, and was associated 
 
43 with increased nuclear accumulation of G-actin. Conversely, treatment with 1,25D enhanced 
 
44 matrix invasion. This was independent of the nuclear vitamin D receptor but was associated with 
 
45 enhanced ERK phosphorylation, and inhibition of ERK kinase suppressed trophoblast matrix 
 
46 invasion. When cultured with serum from pregnant women, trophoblast matrix invasion correlated 
 
47 with DBP concentration, and DBP was lower in first trimester serum from women who later 
 
48 developed preeclampsia. These data show that trophoblast matrix invasion involves uptake of 
 
49 serum DBP and associated intracellular actin binding and homeostasis. DBP is a potential marker 
 
50 of placentation disorders such as preeclampsia and may also provide a therapeutic option for 
 























59 Vitamin D binding protein (DBP) is a serum globulin associated with systemic transport of vitamin 
 
60 D metabolites (Chun 2012). Glomerular filtration of DBP and its primary cargo, the main circulating 
 
61 form of vitamin D, 25-hydroxyvitamin D (25D), play a pivotal role in vitamin D endocrinology. 
 
62 Recovery of the DBP-25D complex from glomerular filtrate by proximal convoluted tubular cells 
 
63 of the kidney occurs via endocytic uptake of DBP utilising the megalin receptor. This recovery of 
 
64 25D from glomerular filtrates faciltates renal conversion of 25D to active 1,25-dihydroxyvitamin D 
 
65 (1,25D) (Nykjaer, et al. 1999), via the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1), 
 
66 which is also expressed by proximal tubule cells (Zehnder, et al. 1999). Although only 5% of DBP 
 
67 molecules have vitamin D metabolites bound at any given time, megalin-mediated uptake of DBP 
 
68 in proximal tubules also functions to maintain circulating levels of 25D. Mice with knockout of the 
 
69 DBP (Gc) (Safadi, et al. 1999) or megalin (Lrp2) genes (Nykjaer et al. 1999) have extremely low 
 
70 serum levels of 25D, and single nucleotide polymorphisms (SNPs) of the human DBP gene (GC) 
 




73 Megalin is present at several extra-renal sites (Lundgren, et al. 1997), including the placenta 
 
74 (Burke, et al. 2013), where its expression is coincident with DBP (Ma, et al. 2012). Both maternal 
 
75 decidua and fetal trophoblast also express CYP27B1 and the intracellular vitamin D receptor 
 
76 (VDR) for 1,25D (Zehnder, et al. 2001). Thus, the placenta, like the kidney, has a significant 
 
77 capacity for vitamin D metabolism that may be supported by megalin-mediated DBP transport. 
 
78 Circulating levels of 1,25D (Kumar, et al. 1979) and DBP (Jorgensen, et al. 2004) are increased 
 
79 during early pregnancy but the precise function of DBP in the placenta is unclear and may involve 
 
80 known vitamin D-independent functions of DBP. These include a potential role as a macrophage- 
 
81 activation factor (Benis and Schneider 1996), and in fatty acid transport (Calvo and Ena 1989). 
 
82 DBP also binds the monomeric, globular, form of actin (G-actin) with high affinity, allowing DBP 
 
83 to compete with other established actin-regulating factors such as gelsolin which incorporates G- 








84 actin into filamentous actin (F-actin)(Otterbein, et al. 2002). In this way, DBP can also function as 
 
85 a systemic actin-scavenger, with a potential role in protecting against tissue damage due to 
 
86 systemic F-actin accumulation (Luebbering, et al. 2020), although the DBP-actin complex may 
 




89 Variations in serum vitamin D metabolites (Bodnar, et al. 2007; Wei, et al. 2013) and SNPs for 
 
90 GC (Baca, et al. 2018; Naidoo, et al. 2019) have been linked to adverse events in pregnancy such 
 
91 as the malplacentation disorder preeclampsia but the mechanisms underpinning these 
 
92 associations remain unclear. In particular, although DBP and vitamin D metabolites are abundant 
 
93 in the placenta, their role in placental development has yet to be defined. In the current study we 
 
94 show that trophoblast cells internalize extracellular DBP and that this process is essential for 
 
95 trophoblast matrix invasion. Decreased cellular uptake of DBP was associated with increased 
 
96 nuclear accumulation of G-actin and decreased capacity for trophoblast matrix invasion. The 
 
97 concentration of DBP in serum from pregnant women correlated with capacity for trophoblast 
 
98 matrix invasion in ex vivo assays, and DBP levels in first trimester pregnancy serum samples 
 
99 were significantly lower in women who developed preeclampsia later in pregnancy. These data 
 
100 indicate that serum DBP is a crucial circulating factor in early pregnancy. Trophoblast uptake of 
 
101 maternal DBP may be pivotal to early placental development, with dysregulation of this process 
 




104 Materials and methods 
 
105 Cell culture and reagents 
 
106 Choriocarcinoma trophoblastic cells lines JEG3 and BeWo (European Collection of Authenticated 
 
107 Cell Cultures), non-neoplastic first trimester extravillous like trophoblasts cells HTR8 (a kind gift 
 
108 from Dr S. Gross, Aston University) were routinely cultured at 37°C and 5% CO2 in MEM (Sigma 
 








110 W/L-Glutamine (Thermo Fisher) respectively, each supplemented with 10% fetal bovine serum 
 
111 (FBS) (Thermo Fisher Scientific). Thyroid papillary carcinoma (TPC) cell line (a kind gift from 
 
112 Prof. CJ McCabe, University of Birmingham) was cultured in RPMI-1640 Medium W/L-Glutamine 
 
113 (Thermo Fisher) supplemented with 10% FBS. Cells were cultured on growth factor reduced 
 
114 Matrigel pre-coated transwell plates (Corning® BioCoat™ Matrigel®, 8.0 micron). All cells were 
 
115 treated for 2-72 hours (h) with vehicle (0.1% ethanol), 1,25D (1-100 nM) (Enzo Lifesciences), DBP 
 
116 (East Coast Bio) (3 µM), the megalin inhibitor receptor associated protein (RAP), (1 µM) Enzo 
 




119 Cell proliferation 
 
120 All cells were seeded at a concentration of 5x103 cells/ well in a 24-well plate, and proliferation 
 
121 assessed by quantification of nuclear incorporation of 5-bromo-2-deoxyuridine (BrdU) using a 
 




124 Matrix invasion 
 
125 Cell invasion of matrix was evaluated using growth-factor-reduced Matrigel-coated transwells. All 
 
126 cells were treated with pre-warmed culture medium containing 2% FBS for 24 h prior to passage. 
 
127 Cell were then trypsinised, re-suspended in 2% FBS culture medium and 5x104 cells per well 
 
128 seeded onto transwell inserts in the upper chamber of each well. Complete media (with 10% FBS) 
 
129 was added to the lower chamber of each transwell. Immediately after seeding cells were treated 
 
130 according to specific experiments for a further 48 h. The lower surface of the transwell inserts was 
 
131 then washed with PBS then 95% ethanol and stained with Haematoxylin (Sigma), followed by 
 
132 washing with Scott’s water, and further staining with Eosin-Y (VWR chemicals). After further 
 
133 washes with 70% ethanol and 99% ethanol, transwell Matrigel inserts were dried at room 
 
134 temperature, and the lower surface of each insert imaged using a microscope (Leica DM ILM 
 
135 inverted) at x10 magnification. Under blinded conditions, 5 images per well were taken for each 








136 well and the number of invaded cells were manually counted for each image. Each transwell was 
 




139 In some experiments, quantification of invaded cells in the Matrigel transwell assays was carried 
 
140 out using Crystal violet (Sigma) to stain the invading cells, and acetic acid to solubilise the 1% 
 
141 Crystal violet stain. Cell seeding and incubation were carried out as described above. Invaded 
 
142 cells on the transwell were washed twice with PBS, then stained with 1% crystal violet for 10min, 
 
143 and then washed again with PBS. Following this, transwell inserts were left to dry at room 
 
144 temperature. Images of each insert were taken for counting (5 quadrants per transwell as 
 
145 explained above). Transwell inserts were then immersed in 400 µl 30% acetic acid (in 24 well 
 
146 plate) and shaken for 10 min at room temperature. Following this, 100 µl of the blue stained acetic 
 
147 acid solution was pipetted into triplicate wells in a 96 well plate and absorbance measured at 590 
 
148 nm and 405 nm (OD value) using an ELISA plate reader (SpectraMax ABS, Molecular devices, 
 
149 San Jose). Each experiment was repeated multiple times as indicated and values reported as 
 
150 percentage (%). The total number of cells invading through transwell was calculated by converting 
 
151 absorbance values to cell numbers using a standard curve with known cell numbers. Percentage 
 




154 Quantitative RT-PCR 
 
155 Total RNA was extracted from cell cultures using Trizol reagent (Sigma Aldrich, Lot no. 
 
156 BCBV4616) as per manufacturer’s instructions. For each sample, 200-400 ng RNA was then 
 
157 reverse transcribed using a Reverse Transcription Kit (Thermo Fisher Scientific, 4368814) 
 
158 according to the manufacturer’s instruction, and cDNAs amplified for the following genes: vitamin 
 
159 D receptor (VDR) (Thermo Fisher, Hs00172113_m1); 24-hydroxylase (CYP24A1) (Thermo 
 
160 Fisher, Hs00167999_m1); vitamin D binding protein (DBP/Gc) (Thermo Fisher, 
 








162 Tissue inhibitor of metalloproteinase 1 (TIMP1) (Thermo Fisher, Hs01092512_g1); megalin/LRP2 
 
163 (Thermo Fisher Hs00189742_m1); Beta-actin (Hs01060665_g1), GAPDH (Hs02758991_g1) and 
 
164 18S rRNA (Hs99999901_s1) were used as housekeeping internal standards. cDNA amplification 
 
165 was carried out using GoTaq qPCR MasterMix (ThermoFisher, 4318157) in a thermocycler 
 
166 (GeneAmp PCR System 2700, ThermoFisher Scientific) with amplification at 50 °C for 2 min and 
 
167 95 °C for 10 min followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min. Differences in mRNA 
 
168 expression were assessed statistically using raw δCt values VDR mRNA Where δCt= Ct target 
 




171 Western Blot Analysis 
 
172 Whole cell protein lysates were extracted using radioimmunoprecipitation assay (RIPA) buffer 
 
173 (with Tris-EDTA) with protease and phosphatase inhibitor. Cytoplasmic and nuclear proteins were 
 
174 fractionated using NE-PER nuclear and cytoplasmic extraction reagents (Thermo Fisher 
 
175 Scientific), per manufacturer instructions. Proteins were separated using SDS-polyacrylamide 
 
176 (10%) gel electrophoresis, transferred to nitrocellulose membranes, and probed with various 
 
177 antibodies using chemiluminescence (Pierce ECL Plus, Thermo Fisher Scientific). Proteins 
 
178 quantified by Western blotting were: VDR (Santa Cruz, D-6), DBP (Abcam), ERK1/2 
 
179 (ThermoFisher, MA5-15134, K.913.4), pERK 1/2 (ThermoFisher,MA5-15173, S.812.9). β-actin 
 
180 (Abcam) was used as housekeeping control protein for whole cell lysates and cytoplasmic 
 
181 proteins (Supplemental Table 1). Lamin B1 (Abcam) was used as a housekeeping protein for 
 
182 nuclear lysates, and Na-K-ATPase (Abcam) was used as a housekeeping protein for membrane 
 
183 lysates. Secondary antibodies used were goat anti-mouse HRP (Abcam), and goat anti-rabbit 
 




186 Immunofluorescence analysis of cellular protein expression 








187 Cells were cultured on coverslips or Matrigel transwell inserts using 2% FBS culture medium. The 
 
188 resulting monolayers were washed x3 with PBS and fixed in 3% paraformaldehyde at room 
 
189 temperature for 20 min. Cells were then incubated for 10 min in chilled 100% methanol or Triton 
 
190 X-100 (Sigma) according to the antibody used. This was followed by a PBS wash and blocking 
 
191 with 10% neonatal calf serum (N4637) for 30 min. Incubation with primary antibody 
 
192 (Supplemental Table 1) in 1% bovine serum albumin (Merck) in PBS was then carried out for 1 
 
193 h at room temperature, followed x3 washes with PBS. Preparations were then incubated with 
 
194 secondary antibody or Hoechst stain for nucleus (Invitrogen) at 1:1000 dilution, mixed with 1% 
 
195 neonatal calf serum and 1% bovine serum albumin. Secondaries used were Alexa Fluor 488 - 
 
196 conjugated goat anti-mouse IgG (ThermoFisher) and Alexa Fluor 594 -conjugated goat anti-rabbit 
 
197 IgG (ThermoFisher, A11037) at 1:250 dilution, for each coverslip. Following this, the conjugated 
 
198 antibodies were mixed with 1% neonatal calf serum and 1% bovine serum albumin, and the 
 
199 samples were incubated for 1 h in these antibodies. This was followed by washing 3 times with 
 
200 PBS. The coverslips and the Matrigel transwell base were then mounted on Thermo Fisher 
 
201 ProLong™ Diamond Antifade Mountant media (ThermoFisher). Slides were imaged with Confocal 
 
202 Microscope Zeiss LSM 780, and analysed and quantified using ImageJ Fiji (NIH, USA). 
 
203 Expression levels for target proteins were determined using ImageJ Fiji software (NIH, USA) by 
 
204 measuring “area of fluorescence colour” subtracted from “integrated density”, then multiplied by 
 




207 siRNA knockdown of VDR 
 
208 VDR siRNA was used to knockdown VDR mRNA expression in JEG3 and TPC cells. ON- 
 
209 TARGETplus Human VDR (7421 siRNA (Dharmacon, L-003448-00-0010) was used for VDR 
 
210 knockdown at a concentration of 100 nM. A scrambled sequence siRNA (Ambion, 4390843) (100 
 
211 nM) was included as a negative control. Transfections were performed in transwells (24 wells) 
 








213 ThermoFisher) and  6μl  Lipofectamine RNAiMAX  transfection  reagent (ThermoFisher)  were 
 
214 combined and incubated for 5 min at room temperature. Following this, 2.5 μl of siRNA per well 
 
215 was added to the solution and incubated for 20 minutes. 500μl of the above final solution was 
 
216 then added to each well (100 nM siRNA concentration, from a stock solution of 40 µM) and cells 
 
217 incubated for 48 h. All transfections were performed with 10,000 cells seeded on Matrigel and 
 
218 cultured for 48 h. Transfection medium was then replaced with respective regular cell culture 
 
219 medium prior to immunofluorescence and/or invasion assay. Each experiment was carried out in 
 




222 Analysis of serum DBP concentrations 
 
223 Human serum samples from pregnant women were obtained from two sources. The first set of 
 
224 samples were obtained as part of previous studies of maternal serum and placental/ decidual 
 
225 concentrations of vitamin D metabolites and DBP in 1st, 2nd and 3rd trimester pregnancies (Ethics: 
 
226 14/WM/1146, obtained from West Midlands - Edgbaston Research Ethics Committee) (Tamblyn, 
 
227 et al. 2017). For these samples, serum, placental and decidual human DBP concentrations were 
 
228 previously determined (Tamblyn et al. 2017), and serum samples were used to prepare patient 
 
229 specific JEG3 Matrigel invasion assays. The second set of samples were obtained from University 
 
230 of Cork, Cork, Ireland as part of a study to assess vitamin D metabolite concentrations in serum 
 
231 and urine from pregnant women at 1st trimester of pregnancy, 50% of whom went on to develop 
 
232 preeclampsia (Clinical Research Ethics Committee of the Cork Teaching Hospital: 
 
233 ECM5(10)05/02/08), amendment 14/WM/1146 - RG_14-194 2 and material transfer agreement 
 
234 15.04.2016 15-1386)(Tamblyn, et al. 2018). Using these samples, an ELISA (Enzyme-linked 
 
235 Immune Sorbent Assay) Kit (K2314, Immundiagnostik, Bensheim was used to quantify serum 
 













239 All experiments were carried out in replicate wells according to experiment and repeated 3 to 4 
 
240 times with separate cultures as indicated. One-Way ANOVA and t-test (parametric data) was 
 
241 performed with mean and the 95% confidence interval (GraphPad PRISM (Version 8.0, La Jolla, CA). A p- 
 






245 DBP and VDR are present in trophoblasts cultured on Matrigel 
 
246 VDR and DBP were detectable in JEG3, BeWo and HTR8 trophoblasts, as well as TPC thyroid 
 
247 carcinomas cells (Figure 1A). VDR expression was significantly lower in TPC cells compared to 
 
248 trophoblastic cells (Figure 1B), but increased in these cells with 1,25D. Both trophoblast and TPC 
 




251 1,25D promotes trophoblast matrix invasion 
 
252 Although trophoblasts expressed VDR, mRNA for the VDR-target gene CYP24A1 was 
 
253 undetectable in JEG3, BeWo and HTR8 cells even in the presence of 1,25D (Figure 2A). By 
 
254 contrast, vehicle-treated TPC cells showed low CYP24A1 mRNA, which increased dramatically 
 
255 with 1,25D. TPC cells also showed a significant antiproliferative response to 1,25D, whereas 
 
256 JEG3, BeWo and HTR8 cells showed no response (Figure 2B). For JEG3, BeWo and HTR8 cell 
 
257 Matrigel invasion increased significantly following treatment with 1,25D, whilst 1,25D inhibited 
 
258 matrix invasion by TPC cells (Figure 2C). Pro-invasive effects of 1,25D on trophoblast cells were 
 
259 associated with increased expression of MMP2 and decreased expression of its inhibitor, TIMP1. 
 
260 By contrast, the anti-invasion effect of 1,25D (100 nM) on TPC cells was associated with 
 










263 Knockdown of VDR protein (Figure 3A and 3B) using siRNA had no effect on JEG3 Matrigel 
 
264 invasion in the presence or absence of 1,25D (Figure 3C). In TPC cells, knockdown of VDR 
 
265 suppressed Matrigel invasion significantly, but treatment with 1,25D did not suppress invasion in 
 
266 VDR knockdown TPC cells. These data indicate that the stimulation of trophoblast matrix invasion 
 




269 Intracellular expression of DBP is due to uptake of serum DBP 
 
270 JEG3 cells cultured in medium supplemented with serum from wild type (DBP+/+) mice showed 
 
271 low levels of expression of the gene for DBP (GC) and the DBP membrane receptor megalin 
 
272 (LRP3) (Figure 4A). Expression of mRNA for GC and LRP2 was enhanced significantly following 
 
273 treatment with 1,25D. JEG3 cells cultured in medium supplemented with serum from DBP 
 
274 knockout (DBP-/-) mice showed lower baseline expression of GC and LRP2 relative to cells 
 
275 cultured with DBP+/+ serum. Expression of LRP3 in JEG3 cells cultured with DBP-/- serum was 
 
276 enhanced by treatment with 1,25D in a similar fashion to DBP+/+ cells (Figure 4A). DBP+/+ 
 
277 serum-cultured JEG3 cells also expressed protein for DBP and megalin, but DBP protein 
 
278 expression was significantly decreased in cells cultured with DBP-/- serum (Figure 4B and 4C). 
 
279 By contrast, megalin protein levels increased in DBP-/- JEG3 cells (Figure 4C). These data 
 
280 suggest that although JEG3 cells express low levels of mRNA for GC and LRP2, the presence of 
 




283 JEG3 cells cultured in medium with serum from DBP-/- mice showed significantly lower matrix 
 
284 invasion than cells cultured with DBP+/+ serum (p=0.0007). Unlike DBP+/+ cells, cells cultured in 
 
285 DBP-/- serum showed no enhanced invasion response when treated with 1,25D (Figure 4D). 
 
286 Decreased invasion by JEG3 cells cultured in DBP-/- medium was characterised by decreased 
 
287 expression of mRNA for matrix metalloproteinase 2 (MMP2) and, unlike DBP+/+ cultures, DBP-/- 
 
288 cells showed no MMP2 response to 1,25D (Figure 4E). Conversely, DBP-/- cultures of JEG3 cells 








289 showed higher levels of mRNA for tissue inhibitor of metalloproteinase-1 (TIMP1) than DBP+/+ 
 




292 JEG3 cells treated with the megalin inhibitor RAP showed decreased expression of DBP (Figure 
 
293 4F and 4G). Although RAP acts to inhibit endocytic internalisation of megalin-DBP, it also 
 
294 suppressed cellular expression of megalin (Figure 4F and 4G), consistent with previously 
 
295 reported studies (Birn, et al. 2000). JEG3 cells incubated with the megalin-inhibitor RAP also 
 
296 showed significantly lower levels of Matrigel invasion relative to vehicle-treated cells (Figure 4H). 
 
297 These data indicate that inhibition of cellular uptake of DBP via megalin profoundly suppresses 
 




300 Effects of DBP and 1,25D on trophoblast matrix invasion involve ERK phosphorylation 
 
301 Previous studies have shown that enhanced matrix invasion by trophoblasts following treatment 
 
302 with 1,25D involves intracellular ERK signalling (Kim, et al. 2018). JEG3, BeWo and HTR8 
 
303 trophoblasts showed increased nuclear phosphorylated ERK (pERK) following treatment with 
 
304 1,25D (Figure 5A), and cytoplasmic and nuclear pERK were blocked when the cells were 
 
305 incubated with the ERK inhibitor U0126 in the presence or absence of 1,25D (Figure 5A and 5B). 
 
306 U0126 also blocked intracellular uptake of DBP into JEG3 cells but had no effect on VDR 
 
307 expression (Figure 5C). Co-treatment with 1,25D partially abrogated suppressive effects of 
 
308 U0126 on intracellular DBP in JEG3 cells (Figure 5C). Similar results were also obtained for 
 
309 BeWo and HTR8 cells (Supplemental Figure 1). In JEG3, BeWo and HTR8 cells U0126 
 
310 suppressed Matrigel invasion, and this was unaffected by co-treatment with 1,25D (Figure 5D). 
 












314 DBP binds vitamin D metabolites with high affinity but is also a potent scavenger of G-actin 
 
315 (Delanghe, et al. 2015). Immunofluorescence analysis of F-actin and G-actin in JEG3 and HTR8 
 
316 cells cultured in medium supplemented with either DBP+/+ or DBP-/- serum showed different 
 
317 patterns of intracellular actin. In the presence of extracellular DBP (DBP+/+ serum) cells showed 
 
318 only low levels of G-actin but this increased significantly in cells cultured without DBP (DBP-/- 
 
319 serum) (Figure 6A and 6B). Lack of DBP was also associated with decreased cellular F-actin in 
 
320 JEG3 and HTR8 cells (Figure 6B). In the absence of DBP, the ratio of G-actin/F-actin increased 
 




323 Serum concentrations of DBP and 1,25D define matrix invasion by trophoblasts 
 
324 Serum concentrations of maternal 1,25D and DBP increase during pregnancy but vary 
 
325 considerably within cohorts (Tamblyn et al. 2017). To assess the impact of these two factors on 
 
326 trophoblast matrix invasion, serum from 14 women in the first trimester of pregnancy was used to 
 
327 generate individual JEG3 Matrigel invasion cultures. Data in Figure 7A showed that serum DBP 
 
328 concentrations correlate significantly with Matrigel invasion by JEG3 cells. There was also a trend 
 
329 for correlation between invasion and serum levels of 1,25D (Figure 7B), but no correlation with 
 
330 serum 25D (Figure 7C). When normalised to serum levels of 1,25D, DBP concentrations showed 
 
331 an even stronger correlation with trophoblast invasion (Figure 7D), but no similar effect was 
 




334 These data indicate that serum levels of both DBP and 1,25D can influence trophoblast matrix 
 
335 invasion. To determine possible clinical implications of this observation, concentrations of DBP 
 
336 were analysed in serum samples from a cohort of first trimester pregnancies in which 50% of 
 
337 women went on to have normal healthy deliveries, whilst 50% went on to develop the hypertensive 
 
338 disorder preeclampsia. Data in Figure 7F showed that women with healthy pregnancies had 








339 significantly higher serum DBP (mean: 869.5 ng/ml, 95% CI: 812.7 – 919.1) than women who 
 






343 We have shown previously that placental levels of DBP correlate directly with maternal circulating 
 
344 DBP across gestation (Tamblyn et al. 2017). In the current study, we show that although 
 
345 trophoblast cells express low levels of GC mRNA, the presence of DBP protein in these cells is 
 
346 due primarily to megalin-mediated endocytic uptake. Megalin and its co-receptor cubilin have 
 
347 been shown to be expressed by trophoblastic tissues within the placenta (Akour, et al. 2013), by 
 
348 primary cultures of trophoblasts (Longtine, et al. 2017), and by trophoblast cell lines cultured on 
 
349 Matrigel (Akour, et al. 2015). Interestingly, preliminary analysis of trophoblastic cells cultured 
 
350 using conventional plasticware indicates that these cells do not exhibit intracellular DBP 
 
351 (Supplemental Figure 2). Thus, interaction with matrix components may be a key factor in 
 
352 cellular acquisition of DBP, presumably via enhanced expression of megalin. Although the 
 
353 promiscuous nature of megalin-mediated endocytosis means that it is involved in the placental 
 
354 transport of a wide range of potential ligands (Akour et al. 2013), its role in DBP uptake by placenta 
 
355 cells is still not clear. Here we show that inhibition of DBP uptake by either ablation of DBP in 
 
356 serum, or inhibition of megalin suppressed Matrigel invasion by JEG3 cells, highlighting an 
 




359 Trophoblastic uptake of DBP may facilitate the cellular movement and metabolism of vitamin D 
 
360 within the placenta. The transfer of 25D and 1,25D from mother to fetus is thought to occur by 
 
361 passive diffusion of these lipid soluble molecules across the placenta (Ryan and Kovacs 2020). 
 
362 However, the presence of megalin in placental tissues (Burke et al. 2013; Ma et al. 2012), 
 
363 suggests that transport of vitamin D metabolites across the placenta may be facilitated by binding 
 








365 consequence of placental uptake of DBP. In the circulation serum DBP also functions as a potent 
 
366 actin-binder (Otterbein et al. 2002) protecting against tissue damage due to systemic F-actin 
 
367 accumulation (Gomme and Bertolini 2004). In recent studies using alpha-cells of the Islets of 
 
368 Langerhans we have shown that cytoplasmic DBP also participates in intracellular actin 
 
369 homeostasis, with concomitant effects on glucagon secretion (Viloria, et al. 2020). We therefore 
 
370 postulated that DBP in trophoblast cells interacts with intracellular actin in a similar fashion. The 
 
371 cellular actions of G- and F-actin are complex, and actin homeostasis plays a crucial role in 
 
372 regulating cell differentiation and function (Skruber, et al. 2018). A reduced G-/F-actin ratio has 
 
373 been associated with increased matrix invasion by trophoblast giant cells (Chakraborty and Ain 
 
374 2018). In the current study we show that in the absence of DBP there is a 4-5-fold increase in the 
 
375 G-/F-actin ratio for JEG3 and HTR8 cells, and this is associated with decreased matrix invasion 
 
376 by these cells. Our data also suggest that the increased intracellular G-actin and decreased matrix 
 
377 invasion in the absence of DBP specifically reflect increased nuclear G-actin expression. Nuclear 
 
378 actin is known to regulate cell differentiation and function (Misu, et al. 2017), but it remains to be 
 
379 determined if this plays a role in trophoblast cell biology and, in particular, matrix invasion. It is 
 
380 also possible that DBP acts to modulate actin polymerization to F-actin, and decreased actin 
 




383 DBP may play a pivotal role in coordinating the intracellular functions of both G- and F-actin in 
 
384 trophoblast cells, but this activity appears to be distinct from intracellular DBP in other cell types. 
 
385 In islets of Langerhans, the presence of DBP is due to alpha-cell-specific expression of the DBP 
 
386 gene (GC), rather than cellular uptake of circulating DBP. Using islets isolated from wild type 
 
387 (DBP+/+) and GC knockout (DBP-/-) mice we showed that loss of intracellular DBP was 
 
388 associated with decreased alpha-cell size and glucagon release, with indirect effects on beta-cell 
 
389 insulin release (Viloria et al. 2020). The ratio of G-/F-actin is known to be important for secretory 
 
390 function of islet cells (Kalwat and Thurmond 2013), and DBP-/- alpha-cells showed a shift from 








391 monomeric G-actin expression to increased F-actin (Viloria et al. 2020). Thus in alpha-cells 
 
392 intracellular DBP appears to function by limiting DBP for polymerization to F-actin, while in 
 
393 trophoblasts DBP appears to limit nuclear uptake of G-actin. This dichotomy of function may 
 
394 reflect the endogenous nature of DBP and its specific secretory function of alpha-cells but, 
 
395 nevertheless, underlines the importance of DBP for maintenance of both systemic and 
 
396 intracellular actin homeostasis. This is further illustrated by previously reported studies of hepatic 
 
397 stellate cells which do not express DBP/GC but acquire DBP in a megalin-dependent fashion from 
 
398 hepatocytes which express and secrete DBP (Gressner, et al. 2008). After internalization by 
 
399 hepatic stellate cells, DBP acts to bind intracellular actin, with concomitant effects on 
 




402 Although DBP plays a pivotal role in defining the matrix invasion by trophoblastic cells, our data 
 
403 also indicate a role for DBP’s cargo. Active vitamin D, 1,25D, promoted trophoblast matrix 
 
404 invasion consistent with previous studies of trophoblast cells (Chan, et al. 2015; Kim et al. 2018). 
 
405 This effect was independent of the nuclear VDR and trophoblast cells did not exhibit classical 
 
406 1,25D-VDR responses such as induction of CYP24A1, but instead promoted non-nuclear 
 
407 signalling via induction of pERK. This mechanism is required for trophoblast responses to 1,25D, 
 
408 but also appears to play a fundamental role in promoting trophoblast invasion in general. Inhibition 
 
409 of pERK dramatically suppressed matrix invasion by all three trophoblast cell lines in the presence 
 
410 or absence of 1,25D, and this was associated with complete suppression of intracellular DBP and 
 
411 elevation of nuclear G-actin. Thus, megalin-mediated uptake of DBP by trophoblasts appears to 
 
412 be dependent on ERK phosphorylation, with increased pERK following treatment with 1,25D 
 
413 acting to further enhance matrix invasion. By contrast, in thyroid carcinoma TPC cells 1,25D 
 
414 suppressed matrix invasion, and these cells also demonstrated classical nuclear responses to 
 
415 1,25D, similar to those described for 1,25D and other tumor cells lines (Bao, et al. 2006). Thus, 
 








417 established cellular anti-proliferative/anti-invasion effects of vitamin D, and acts to amplify the 
 




420 Data in Figure 4 and Figure 5 suggest that DBP and its ligand 1,25D act in a coordinated fashion 
 
421 to optimise trophoblast invasion. To test this hypothesis, we used serum from healthy 1st trimester 
 
422 pregnancies to assess matrix invasion capacity for individual pregnant women. The observation 
 
423 that serum DBP levels alone are sufficient to define the magnitude of JEG3 matrix invasion 
 
424 underlined the importance of DBP as a determinant of healthy placenta development. We have 
 
425 shown previously that placental levels of DBP are directly proportional to maternal serum 
 
426 concentrations of DBP (Tamblyn et al. 2017). Data presented here suggest that this, in turn, plays 
 
427 a key role in directing trophoblast function. Although maternal serum 1,25D showed only a trend 
 
428 towards enhanced matrix invasion by JEG3 cells, adjustment of DBP concentrations to account 
 
429 for 1,25D resulted in a stronger correlation with invasion than for DBP alone. Collectively these 
 
430 data endorse a mechanistic model in which 1,25D acts to promote DBP uptake and enhance 
 
431 trophoblast invasion. Nevertheless, in 1st trimester serum samples DBP concentration alone was 
 
432 sufficient to discriminate between women who went on to healthy pregnancies and those who 
 
433 developed preeclampsia. This is in stark contrast to measurement of vitamin D metabolites such 
 
434 as 25D and 1,25D which showed no difference between these two populations of women 
 
435 (Tamblyn et al. 2018). It is also important to recognise that in serum invasion experiments serum 
 
436 25D had no impact on matrix invasion by JEG3 cells, even when used to adjust DBP levels. 
 
437 Serum 25D levels are used almost exclusively as the marker of vitamin D ‘status’ for studies of 
 
438 human health. Based on data presented in the current study, we propose that this approach is an 
 
439 oversimplification of the biological action of vitamin D, with both DBP and active 1,25D 
 
440 coordinating important molecular, cellular and clinical actions of vitamin D. 
 
441 441 








442 Data presented here suggest an entirely new paradigm for vitamin D and placental function in 
 
443 which the serum vitamin D carrier DBP plays a pivotal role in trophoblast matrix invasion (Figure 
 
444 8). The fact that trophoblasts acquire exogenous DBP from using megalin-mediated endocytosis 
 
445 provides a mechanism by which circulating maternal levels of DBP can influence fetal trophoblast 
 
446 function. Serum DBP concentrations are increased in pregnant versus non-pregnant women but 
 
447 the function of this is unclear. We propose that lower serum levels of DBP during pregnancy may 
 
448 impair matrix invasion by fetal trophoblasts. Consistent with this we show that circulating 1st 
 
449 trimester levels of DBP are lower in women who go on to develop the malplacentation disorder 
 
450 preeclampsia. This is supported by recent studies of women with type 1 diabetes who develop 
 
451 preeclampsia, where decreased serum levels of DBP were also observed (Kelly, et al. 2020). In 
 
452 this report the lower circulating levels of DBP were assessed in the context of free and bound 
 
453 vitamin D metabolite levels, but direct actions of DBP may also occur in these women. Thus, 
 
454 circulating DBP may be a novel marker of preeclampsia risk. However, use of DBP as a systemic 
 
455 actin scavenger has also been proposed as strategy for the prevention of endothelial injury 
 
456 associated with bone marrow transplantation (Luebbering et al. 2020). It is therefore interesting 
 
457 to speculate that restoration of low serum DBP in pregnant women may provide a new approach 
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468 Figure legends 
 
469 Figure 1. Expression of VDR and DBP in trophoblasts and thyroid cells. 1A. Expression of 
 
470 protein for the vitamin D receptor (VDR, pink) and vitamin D binding protein (DBP, red) in JEG3, 
 
471 BeWo, HTR8 and TPC cells cultured on Matrigel in the presence or absence of 1,25D (10 nM, 48 
 
472 h). Immunofluorescence for each protein is shown in combination with nuclear (Hoechst, blue) 
 
473 and membrane (NaK ATPase, green) markers. 1B. Data for total corrected cell fluorescence of 
 
474 VDR and DBP protein expression (mean ± 95% CI) are shown for duplicate images from n= 3-4 
 
475 separate experiments. Statistically different from vehicle-treated control, * p < 0.05, ** p < 0.01, 
 




478 Figure 2. Effects of 1,25D on trophoblasts and TPC cells cultured on Matrigel. 2A. 
 
479 Expression of mRNA (1/δCt) for CYP24A1, and 2B. Cell proliferation (BrdU incorporation, 
 
480 absorbance units) (A) in JEG3, BeWo, HTR8 and TPC cells cultured on Matrigel in the presence 
 
481 or absence of 1,25D (100 nM, 48 h). 2C. Cell matrix invasion (cell number/field of vision) by JEG3, 
 
482 BeWo, HTR8 and TPC cells cultured on Matrigel in the presence or absence of 1,25D (10 nM and 
 
483 100 nM, 48 h). 2D. Expression of mRNA for matrix metalloproteinase 2 (MMP2) and tissue- 
 
484 inhibitor of matrix metalloproteinase 1 (TIMP1) in JEG3, BeWo, HTR8 and TPC cells cultured on 
 
485 Matrigel in the presence or absence of 1,25D (100 nM, 48 hrs). Data for mRNA expression are 
 
486 mean ± 95% CI 1/δCt value for duplicate or single analyses from n=3 separate experiments. Data 
 
487 for cell invasion and cell proliferation assays are mean ± 95% CI, for triplicate or quadruplicate 
 
488 analyses from 3-5 separate experiments. Statistically different from vehicle-treated control, * p < 
 




491 Figure 3. Effect of VDR knockdown on 1,25D-induced cell matrix invasion. Effect of siRNA 
 
492 knockdown of VDR on (3A) VDR mRNA expression in JEG3 cells (3B) VDR (pink) and DBP (red) 
 
493 protein expression. Immunofluorescence for each protein is shown in combination with nuclear 








494 (Hoechst, blue) and membrane (NaK ATPase, green) markers. Effect of siRNA knockdown of 
 
495 VDR on (3C) cell matrix invasion (cell number/field of vision) by JEG3 and TPC cells cultured on 
 
496 Matrigel in the presence or absence of 1,25D (100 nM, 48 h). Data for cell fluorescence are mean 
 
497 ± 95% CI, for quadruplicate analyses from 4 separate experiments. Data for matrix invasion 
 
498 fluorescence are mean ± 95% CI, for duplicate analyses from 3 separate experiments. Statistically 
 




501 Figure 4. Effect of serum DBP and megalin function on intracellular DBP and trophoblast 
 
502 function. 4A. Effect of wild type (DBP+/+) and DBP knockout (DBP-/-) mouse serum on DBP 
 
503 (red) and megalin (pink) protein expression in Matrigel cultured JEG3 cells. Immunofluorescence 
 
504 for each protein is shown in combination with nuclear (Hoechst, blue) and membrane (NaK 
 
505 ATPase, green) markers. 4B. Total corrected cell fluorescence for DBP and megalin protein 
 
506 expression 4C. Matrigel invasion. 4D. Expression of mRNA for MMP2, TIMP1, VDR, DBP and 
 
507 megalin (LRP2) in JEG3 cells cultured in medium with DBP+/+ or DBP-/- serum in the presence 
 
508 or absence of 1,25D (100 nM, 48 h). 4E, 4F and 4G. DBP and megalin immunofluorescence, and 
 
509 Matrigel invasion, in JEG3 cells cultured in FBS-supplemented medium in the absence or 
 
510 presence of the megalin inhibitor RAP (1 µM)). Data for immunofluorescence are the mean ± 95% 
 
511 CI for duplicate analyses from n=4 separate experiments. Data for matrix invasion are the mean 
 
512 ± 95% CI for duplicate or single analyses from n=3 separate experiments. Data for mRNA 
 
513 expression are the mean ± 95% CI for single analyses from n=3 separate experiments. 
 






517 Figure 5. ERK kinase activity and responses to 1,25D in trophoblastic and thyroid cells. 
 
518 5A. Western blot analysis of cytoplasmic and nuclear ERK and pERK in JEG3, BeWo and TPC 
 








520 Effect of ERK kinase inhibitor U0126 on pERK in JEG3 cells cultured on Matrigel with or without 
 
521 1,25D (100 nM, 48 h). 5C. Effect of ERK kinase inhibitor U0126 on DBP (red) and VDR (pink) 
 
522 protein expression in Matrigel cultured JEG3 cells. Immunofluorescence for each protein is shown 
 
523 in combination with nuclear (Hoechst, blue) and membrane (NaK ATPase, green) markers. 5D. 
 
524 Matrigel invasion by JEG3, BeWo, HTR8 and TPC cells treated with 1,25D (100 nM, 48 hrs) in 
 
525 the presence or absence of the ERK kinase inhibitor U0126 and in the presence or absence of 
 
526 1,25D (100 nM, 48 h). Data showing the number of matrix invading cells/field of vision are the 
 
527 mean ± 95% CI for triplicate analyses from 3 separate experiments. Statistically different from 
 




530 Figure 6. G-actin, F-actin and megalin concentration with respect to serum DBP level and 
 
531 presence of serum 1,25D (100 nM, 48 h). 6A. Effects of wild type mice (DBP +/+) and knockout 
 
532 mice (DBP -/-) serum on expression level of F-actin (green), G-actin (red) and DBP (yellow) in 
 
533 JEG3 and HTR8 cells. Immunofluorescence for each protein is shown in combination with nuclear 
 
534 (Hoechst, blue) marker. 6B. Data for total corrected cell fluorescence of F-actin and G-actin 
 
535 protein expression (mean ± 95% CI) for images from 6A, with n=3 separate experiments and 
 
536 showing multiple replicates for each experiment. 6C. Ratio of total corrected cell fluorescence of 
 
537 G-actin and F-actin protein expression (mean ± 95% CI) for JEG3 and HTR8 data from 6B. 
 




540 Figure 7. DBP from pregnancy serum samples defines matrix invasion by JEG3 cells, and 
 
541 is decreased in women who later develop preeclampsia . 7A-Correlation of serum DBP, 
 
542 1,25D, and 25D with Matrigel invasion by JEG3 cells cultured in medium supplemented with 
 
543 pregnancy serum samples. 7B. Correlation of DBP adjusted for 1,25D or 25D with invasion of 
 
544 Matrigel by JEG3 cells for n=14 pregnancy serum samples. R and p value are shown for each 








545 graph. 7C. Concentration of DBP in first trimester serum samples from women who went on to 
 




548 Figure 8. Schematic representation of the actions of DBP and 1,25D on trophoblast 
 
549 invasion. DBP and 1,25D cooperate to promote matrix invasion by trophoblasts. Inhibition of 
 
550 this cooperative mechanism by ablation of serum DBP, inhibition of ERK kinase or inhibition of 
 




553 Supplemental Figure 1. Effect of ERK kinase inhibition on expression of VDR and DBP in 
 
554 Matrigel cultures of BeWo and HTR8 cells. Immunofluorescence analysis of expression of 
 
555 protein for DBP (red) and VDR (pink) in BeWo and HTR8 cells cultured the presence or absence 
 
556 of 1,25D (100 nM, 48 hrs) without or with the pERK inhibitor U0126. Nuclear (Hoechst, blue) and 
 
557 membrane (NaKATPase, green) are also shown. Scale bar shows 20µm. Images were taken with 
 




560 Supplemental Figure 2. Expression of the vitamin D system and proliferation response in 
 
561 trophoblastic cells cultured on plastic. S2A. Expression of mRNA (1/δCt) for VDR, CYP24A1, 
 
562 and DBP and S2B. Cell proliferation (BrdU incorporation, absorbance units) in JEG3, BeWo, and 
 
563 TPC cells cultured on platic in the presence or absence of 1,25D (100 nM, 48 h). S2C. Expression 
 
564 of protein for the vitamin D receptor (VDR, pink) and vitamin D binding protein (DBP, red) in JEG3 
 
565 and TPC cells cultured on plastic in the presence or absence of 1,25D (100 nM, 48 h). 
 
566 Immunofluorescence for each protein is shown in combination with nuclear (Hoechst, blue) and 
 
567 membrane (NaK ATPase, green) markers. Data (mean ± 95% CI) are shown for n= 3-4 separate 
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Primary antibodies Manufacturer Dilution used 
anti-Vitamin D receptor (VDR) Santa Cruz, D-6: sc-13133 1:50 
anti-Vitamin D Binding protein Abcam, ab65636 1:50 
anti-LRP2 (Megalin) Abcam, ab236244 1:50 
anti-pERK1/2 Cell signalling, 9101L 1:50 
anti-Sodium Potassium ATPase 
antibody-Plasma Membrane Marker 
Alexa Fluor 488 conjugate 
Abcam, ab197713 1:100 
Deoxyribonuclease-1. Alexa Fluor 594 
Conjugate (anti-G-actin) 
ThermoFisher, D12372 1:500 
Phalloidin-. Alexa Fluor 488 conjugate 
(anti-F-actin) 
Abcam, ab176753 1:500 
Western blot analysis 
Primary antibodies Manufacturer Dilution used 
anti-ERK1/2 ThermoFisher, MA5- 
15134, K.913.4 
1:1000 
anti-pERK1/2 ThermoFisher, MA5- 
15173, S.812.9 
1:1000 
anti-β-actin Abcam, ab8227 1:10,000 
Secondary antibodies 
Alexa Fluor 488 -conjugated goat anti- 
mouse IgG 
ThermoFisher, A21235 1:250 
Alexa Fluor 594 -conjugated goat anti- 
rabbit IgG 
ThermoFisher, A11037 1:250 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
